EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

Clinical trial NCT04664179 · RECRUITING

Trial details

NCT number: NCT04664179
Sponsor: Baylor College of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

EBV-Related Hodgkin Lymphoma EBV-Related Lymphoproliferative Disorder EBV Related Non-Hodgkin's Lymphoma

Start date: 2022-10-31
Primary completion: 2027-11-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.